Form D · Biotechnology
Next Science Ltd
Jacksonville, FL · CIK 0001993519
Offering snapshot reported Sep 25, 2023 · SEC filing
- Reported sold
- $807K Offering amount: $807K
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 29, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 25, 2023 | Initial | $807,474 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-492883
Source: Form D, filed Sep 25, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Harry Hall Iv | Director |
| Grant Hummel | Director |
| Matthew Myntti | Executive |
| Gillian Nairn | Executive |
| Dan Spira | Director |
| Aileen Stockburger | Director |
| Jon Swanson | Executive |
| Marc Zimmerman | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
10550 Deerwood Park Blvd #300
Jacksonville, FL, 32256
Jacksonville, FL, 32256